17 October 2011
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, will announce its results for the third quarter ended 1 October 2011 on Friday 4 November 2011 at 7.00am GMT/3.00am Eastern time. This will be followed by a conference call for financial analysts at 8.30am GMT/4.30am Eastern, which can be heard live via audio webcast on the Smith & Nephew website at www.smith-nephew.com and available on the site archive shortly afterwards.
About Us
Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine, Trauma and Clinical Therapies. The Company has distribution channels, purchasing agents and buying entities in over 90 countries worldwide. Annual sales in 2010 were nearly $4.0 billion.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust.
Enquiries:
Investors/Analysts |
|
Kim Gunthorp |
Tel: +44 (0) 20 7401 7646 |
Investor Relations Manager |
|
Smith & Nephew plc |
|
|
|
Media |
|
Jon Coles Brunswick - London |
Tel: +44 (0) 20 7404 5959 |
|
|